Clinical Trials Browser

Phase 1 × Parkinson Disease 4, Autosomal Dominant Lewy Body × trametinib × Clear all

NCT02027961 2019-05-17

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Phase 1 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma, Neoplasm Metastasis